On Monday, Shares of Ford Motor Co. (NYSE:F), gained 0.65% to $15.58.
General Motors Co.’s bread-and-butter Chevrolet brand took the wraps off its new Camaro, revealing a performance version that tops the Ford Mustang’s by 20 horsepower.
GM is boasting that the high-performance SS version of the sixth-generation Camaro, revealed Saturday at Belle Isle on the Detroit River, is the most powerful pony car it has ever built, with a 455-horsepower V-8, contrast with 435 for the Mustang GT. And with regular unleaded gasoline averaging less than $2.70 a gallon — almost a dollar less than a year earlier — muscle cars seem back in vogue.
The automaker reworked the car in an attempt to outsell Ford Motor Co.’s Mustang, as it did from 2010 through 2014. Chevy, which first introduced the Camaro for the 1967 model year, is going after sports car enthusiasts with big, powerful engines and some better technology to improve the Camaro’s handling.
Ford Motor Company manufactures and distributes automobiles worldwide. The company operates through two sectors, Automotive and Financial Services. The Automotive sector develops, manufactures, distributes, and services vehicles, parts, and accessories. It offers vehicles primarily under the Ford and Lincoln brand names.
Shares of Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP), inclined 10.80% to $3.90, during its last trading session.
Synergy Pharmaceuticals, stated its financial results and business update for the first quarter ended March 31, 2015.
First Quarter 2015 and Recent Highlights
Plecanatide
- On January 8, 2015 and January 29, 2015 Synergy declared the completion of patient enrollment in the first and second of two pivotal phase 3 CIC trials, respectively, which are evaluating the safety and efficacy of two plecanatide doses (3.0 and 6.0 mg). Each randomized, 12-week, double-blind, placebo-controlled phase 3 trial is assessing plecanatide, once-daily oral tablet, in about 1350 adult patients with CIC. Synergy plans to declare top-line data results from the first phase 3 CIC trial in 2Q 2015 and top-line data results from the second phase 3 CIC trial are predictable in 3Q 2015. The company plans to file its first new drug application (NDA) with the FDA for plecanatide in the CIC indication in December 2015.
- Synergy continues to progress its pivotal phase 3 clinical development program with plecanatide for irritable bowel syndrome with constipation (IBS-C). The company is presently enrolling patients in the first phase 3 IBS-C trial and it plans to initiate the second phase 3 IBS-C trial in the first half of this year. The phase 3 IBS-C program is evaluating the efficacy and safety of plecanatide 3.0 and 6.0 mg doses, consistent with the ongoing phase 3 CIC program. Each randomized, 12-week, double-blind, placebo-controlled phase 3 trial is predictable to enroll about 1,050 patients with IBS-C. IBS-C patients successfully concluding either of the trials will be offered enrollment into a long a long-term safety trial in order to support the ongoing long-term safety database for the CIC indication. The company plans to declare top-line data results from the first phase 3 IBS-C trial in 4Q 2015 and the second phase 3 IBS-C trial is predictable to readout in the first half of 2016. Synergy plans to file an NDA with plecanatide in the IBS-C indication in the second half of 2016.
Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders; and for the treatment of constipation-predominant irritable bowel syndrome GI disorders.
At the end of Monday’s trade, Shares of EMC Corporation (NYSE:EMC), lost -0.37% to $26.78.
- EMC Corporation, declared free and frictionless access to Software-Defined Storage software to assist propel IT-driven business transformations.
- EMC releases Project CoprHD (“copperhead”), the open source version of EMC ViPR Controller.
- Project CoprHD to be accessible on GitHub for community-driven development of Software-Defined Storage automation.
- EMC releases free unrestricted EMC ScaleIO software download for non-production use.
- EMC previews enterprise-grade enhancements to ScaleIO to support high-performance applications and Infrastructure-as-a-Service.
EMC Corporation develops, delivers, and supports information infrastructure and virtual infrastructure technologies, solutions, and services. It offers enterprise storage systems and software deployed in storage area networks (SAN), networked attached storage (NAS), unified storage combining NAS and SAN, object storage, and/or direct attached storage environments, in addition to provides a portfolio of backup products that support a range of enterprise application workloads.
Finally, Urban Outfitters Inc. (NASDAQ:URBN), ended its last trade with 2.85% gain, and closed at $40.72.
Urban Outfitters, declared net income of $33 million for the three months ended April 30, 2015. Earnings per diluted share were $0.25 for the three months ended April 30, 2015.
Total Company net sales for the first quarter of fiscal 2016 raised 8% over the same quarter last year to a record $739 million. Comparable Retail segment net sales, which comprise our comparable direct-to-consumer channel, raised 4%. Comparable Retail segment net sales raised 17% at Free People, 5% at Urban Outfitters and 1% at the Anthropologie Group. Wholesale segment net sales rose 18%.
For the three months ended April 30, 2015, the gross profit rate reduced by 141 basis points as compared to the preceding year`s comparable period. The decline in gross profit rate was primarily due to lower initial margins at the Urban Outfitters Brand and higher delivery and fulfillment expense across the entire company. The deleverage in delivery and fulfillment expenses were partially due to the enhance in direct-to-consumer penetration and the starting of the South Carolina fulfillment center transition to Gap, Pennsylvania.
As of April 30, 2015, total inventories raised by $49 million, or 14%, on a year-over-year basis. The growth in total inventories is primarily related to an enhance in comparable Retail segment inventories and the acquisition of inventory to stock new and non-comparable stores. Comparable Retail segment inventories raised 8% at cost while decreasing 5% in units.
Urban Outfitters, Inc., a lifestyle specialty retail company, engages in the retail and wholesale of general consumer products. The company operates in two segments, Retail and Wholesale. It serves its customers directly through retail stores, Websites, mobile applications, catalogs, and customer contact centers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
